1.75
Inhibikase Therapeutics Inc Aktie (IKT) Neueste Nachrichten
What moving averages say about Inhibikase Therapeutics Inc.Chart Signals & Verified Short-Term Plans - Newser
Inhibikase Therapeutics: Is the GAAP EPS Loss a Short-Term Hurdle or a Warning Sign? - AInvest
Inhibikase Posts Wider Loss in Q2 - AOL.com
Visual analytics tools that track Inhibikase Therapeutics Inc. performanceMarket Weekly Review & Weekly Chart Analysis and Trade Guides - Newser
Inhibikase Therapeutics Reports Q2 2025 Financials and Progress - TipRanks
How institutional ownership impacts Inhibikase Therapeutics Inc. stockMarket Sentiment Summary & Long-Term Safe Investment Ideas - Newser
Visual trend scoring systems applied to Inhibikase Therapeutics Inc.July 2025 Selloffs & AI Forecast for Swing Trade Picks - Newser
Trend Reversal Possible in Inhibikase Therapeutics Inc. Charts IndicateJuly 2025 Closing Moves & Verified Swing Trading Watchlists - sundaytimes.kr
Inhibikase Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Inhibikase Therapeutics Reports Q2 2025 Financial Results - TipRanks
Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity | IKT Stock News - GuruFocus
Inhibikase Therapeutics, Inc. SEC 10-Q Report - TradingView
Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity - The Manila Times
Inhibikase's PAH Drug Advances to Phase 2b Trial With Promising Efficacy Target in Pulmonary Disease - Stock Titan
What makes Inhibikase Therapeutics Inc. stock price move sharplyJuly 2025 Patterns & Reliable Momentum Entry Alerts - Newser
Chart based analysis of Inhibikase Therapeutics Inc. trendsWeekly Gains Report & AI Powered Market Trend Analysis - Newser
Using fundamentals and technicals on Inhibikase Therapeutics Inc.Weekly Stock Summary & Risk Adjusted Buy and Sell Alerts - Newser
Automated trading signals detected on Inhibikase Therapeutics Inc.Portfolio Return Report & Accurate Buy Signal Notifications - Newser
Real time pattern detection on Inhibikase Therapeutics Inc. stockBollinger Band Squeeze and Expansion Analysis - Newser
Blair William & Co. IL Has $342,000 Stake in Inhibikase Therapeutics, Inc. (NYSE:IKT) - Defense World
New Product Launches: Will They Boost Inhibikase Therapeutics Inc. Stock in 2025Free Watchlist for Smart Swing Trading - Newser
Key metrics from Inhibikase Therapeutics Inc.’s quarterly dataSwing Watchlist With Tight Stop Placement - Newser
What indicators show strength in Inhibikase Therapeutics Inc.Free Real Market Momentum Signal Generator - Newser
How high can Inhibikase Therapeutics Inc. stock goMonthly Long-Term Market Recap and Summary - Newser
Risk vs reward if holding onto Inhibikase Therapeutics Inc.Tactical Trade Setup With Entry Optimizer - Newser
Inhibikase Therapeutics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
What risks could impact Inhibikase Therapeutics Inc. stock performanceFree Weekly Potential Breakout Stock List - Newser
Inhibikase Therapeutics Inc. recovery potential after sell offSmart Risk Strategy with Entry Optimization - Newser
How Inhibikase Therapeutics Inc. stock performs during market volatilitySafe Entry Screening with Data Backed Analysis - Newser
Published on: 2025-08-06 00:58:01 - Newser
Published on: 2025-08-04 16:30:58 - metal.it
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):